Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-10-08 00:08 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Argentina · Brazil · Canada · Czechia · France · Greece · Mexico · Romania · Spain · United States
Registry dates and results
Start: 2025-05-12. Completion: 2027-07 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug) — also listed as: LY3298176
Placebo (drug)
Where the study takes place — 79 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Kaiser Permanente Bonita Medical OfficesBonita, California, United States
Explore the world’s study registries
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Start: 2024-11-26. Completion: 2030-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug) — also listed as: ZepBound
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Baylor University Medical Center, Baylor Charles A Sammons Cancer Center Dallas, Texas, United States Site recruitment: Recruiting
Alcohol Use Disorder; Alcohol Abuse/Dependence; Alcohol Dependence; Alcoholism; Schizophrenia Disorders; Schizophrenia and Disorders With Psychotic Features; Schizophrenia and Schizophrenia Spectrum Psychosis; Schizophrenia
Sponsor
Anders Fink-Jensen, MD, DMSci
Countries with listed sites
Denmark
Registry dates and results
Start: 2025-05-05. Completion: 2028-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug) — also listed as: Mounjaro
Placebo (drug) — also listed as: BD Posiflush (saline)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Department of Psychiatry, Aalborg University Hospital Aalborg, Denmark, Denmark Site recruitment: Recruiting
Psychiatric Center Copenhagen, Frederiksberg Hospital Frederiksberg, Denmark, Denmark Site recruitment: Recruiting
Start: 2026-01-26. Completion: 2026-03-20 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Ultrasonographic evaluation of gastric content (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Hospital Israelita Albert Einstein São Paulo, São Paulo, Brazil Site recruitment: Recruiting
Start: 2023-11-27. Completion: 2026-01-09 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Cagrilintide (drug)
Semaglutide (drug)
Tirzepatide (drug)
Where the study takes place — 46 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Univ of Alabama Birmingham Birmingham, Alabama, United States Site recruitment: Not reported
Chambliss Clinical Trials LLC Montgomery, Alabama, United States Site recruitment: Not reported
FDRC Costa Mesa, California, United States Site recruitment: Not reported
Diablo Clinical Research, Inc. Walnut Creek, California, United States Site recruitment: Not reported
Univ of Colorado at Denver Aurora, Colorado, United States Site recruitment: Not reported
Yale University School Of Medicine New Haven, Connecticut, United States Site recruitment: Not reported
Northeast Research Institute Fleming Island, Florida, United States Site recruitment: Not reported
Jacksonville Ctr For Clin Res Jacksonville, Florida, United States Site recruitment: Not reported
South Broward Research LLC Miramar, Florida, United States Site recruitment: Not reported
Hope Clin Res & Wellness Conyers, Georgia, United States Site recruitment: Not reported
East West Med Res Inst Honolulu, Hawaii, United States Site recruitment: Not reported
Great Lakes Clinical Trials Chicago, Illinois, United States Site recruitment: Not reported
Endeavor Health Skokie, Illinois, United States Site recruitment: Not reported
Evanston Premier Hlthcr Res Skokie, Illinois, United States Site recruitment: Not reported
Midwest Inst For Clin Res Indianapolis, Indiana, United States Site recruitment: Not reported
Northern Pines Hlth Ctr, PC Buckley, Michigan, United States Site recruitment: Not reported
StudyMetrix Research LLC City of Saint Peters, Missouri, United States Site recruitment: Not reported
Comprehensive Weight Ctrl Prog New York, New York, United States Site recruitment: Not reported
University of North Carolina Chapel Hill, North Carolina, United States Site recruitment: Not reported
Medication Mgmnt, LLC_Grnsboro Greensboro, North Carolina, United States Site recruitment: Not reported
PharmQuest Life Sciences LLC Greensboro, North Carolina, United States Site recruitment: Not reported
Accellacare_NC Raleigh, North Carolina, United States Site recruitment: Not reported
Accellacare Wilmington, North Carolina, United States Site recruitment: Not reported
New Venture Medical Research Wadsworth, Ohio, United States Site recruitment: Not reported
Lynn Institute of Norman Norman, Oklahoma, United States Site recruitment: Not reported
The University of Penn Center Philadelphia, Pennsylvania, United States Site recruitment: Not reported
Clinical Res Collaborative Cumberland, Rhode Island, United States Site recruitment: Not reported
Medical University Of South Carolina Charleston, South Carolina, United States Site recruitment: Not reported
Coastal Carolina Res Ctr North Charleston, South Carolina, United States Site recruitment: Not reported
Hillcrest Clinical Research Simpsonville, South Carolina, United States Site recruitment: Not reported
Spartanburg Medical Research Spartanburg, South Carolina, United States Site recruitment: Not reported
Holston Medical Group_Bristol Bristol, Tennessee, United States Site recruitment: Not reported
Holston Medical Group Kingsport, Tennessee, United States Site recruitment: Not reported
Amarillo Med Spec LLP Amarillo, Texas, United States Site recruitment: Not reported
Elligo Clin Res Centre Austin, Texas, United States Site recruitment: Not reported
UT Health University of Texas Bellaire, Texas, United States Site recruitment: Not reported
Baylr Sctt White Rs Inst, Endo Dallas, Texas, United States Site recruitment: Not reported
Velocity Clin Res, Dallas Dallas, Texas, United States Site recruitment: Not reported
UT Southwestern Medical Center-CRU Dallas, Texas, United States Site recruitment: Not reported
DCOL Ctr for Clin Res Longview, Texas, United States Site recruitment: Not reported
Washington Cntr Weight Mgmt Arlington, Virginia, United States Site recruitment: Not reported
Health Res of Hampton Roads Newport News, Virginia, United States Site recruitment: Not reported
National Clin Res Inc. Richmond, Virginia, United States Site recruitment: Not reported
Selma Medical Associates Winchester, Virginia, United States Site recruitment: Not reported
Capital Clin Res Ctr,LLC Olympia, Washington, United States Site recruitment: Not reported
Rainier Clin Res Ctr Inc Renton, Washington, United States Site recruitment: Not reported
Start: 2025-02-01. Completion: 2026-01-18 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide is administered as part of routine clinical care for obesity management, according to standard prescribing practices. Dosing and treatment duration are determined by the treating physician (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Head of bariatric surgery Naples, Italy Site recruitment: Not reported
Start: 2026-01-28. Completion: 2027-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Weight loss and psoriasis treatment (combination_product)
psoriasis treatment (combination_product)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Diabetes Mellitus, Type 2; HFpEF - Heart Failure With Preserved Ejection Fraction
Sponsor
Brigham and Women's Hospital
Countries with listed sites
United States
Registry dates and results
Start: 2025-01-14. Completion: 2025-06-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug)
Semaglutide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Brigham and Women's Hospital Boston, Massachusetts, United States Site recruitment: Not reported
Start: 2025-04-09. Completion: 2026-01-19 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Eloralintide and Tirzepatide (drug) — also listed as: LY3841136
Eloralintide (drug) — also listed as: LY3841136
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Anaheim Clinical Trials, LLC Anaheim, California, United States Site recruitment: Not reported
Fortrea Clinical Research Unit Daytona Beach, Florida, United States Site recruitment: Not reported
Fortrea Clinical Research Unit Dallas, Texas, United States Site recruitment: Not reported
Diabetes Mellitus, Type 2; Heart Failure With Preserved Ejection Fraction (HFPEF)
Sponsor
Brigham and Women's Hospital
Countries with listed sites
United States
Registry dates and results
Start: 2025-01-14. Completion: 2025-06-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug)
Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Brigham and Women's Hospital Boston, Massachusetts, United States Site recruitment: Not reported
Cambridge University Hospitals NHS Foundation Trust
Countries with listed sites
United Kingdom
Registry dates and results
Start: 2026-01. Completion: 2029-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug)
Anti-Hypertensive medications (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Cambridge University Hospitals NHS Foundation Trust Cambridge, Cambridgeshire, United Kingdom Site recruitment: Recruiting
Start: 2026-01. Completion: 2027-03 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug)
Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana Ljubljana, Slovenia Site recruitment: Recruiting
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
PI "National Laboratory Astana", Nazarbayev University Astana, Kazakhstan, Kazakhstan Site recruitment: Not reported
Start: 2025-02-14. Completion: 2026-06 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug) — also listed as: GIP/GLP-1RA
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
DiaCenTRE - Hirslanden Clinique des Grangettes Chêne-Bougeries, Canton of Geneva, Switzerland Site recruitment: Recruiting
Kantonsspital Olten Olten, Canton of Solothurn, Switzerland Site recruitment: Recruiting
Luzerner Kantonspital Lucerne, Switzerland Site recruitment: Recruiting
Start: 2024-05-21. Completion: 2025-06-17 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Apitegromab (drug) — also listed as: SRK-015
Placebo (drug)
Tirzepatide (drug) — also listed as: ZEPBOUND
Where the study takes place — 7 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
ProSciento CRU Chula Vista, California, United States Site recruitment: Not reported
AdventHealth Translational Research Institute Orlando, Florida, United States Site recruitment: Not reported
Great Lakes Clinical Trials, LLC d/b/a Flourish Research Chicago, Illinois, United States Site recruitment: Not reported
Tandem Clinical Research GI, LLC Marrero, Louisiana, United States Site recruitment: Not reported
Alliance for Multispecialty Research, LLC Norman, Oklahoma, United States Site recruitment: Not reported
Apex Mobile Clinical Research Bellaire, Texas, United States Site recruitment: Not reported
Clinical Trials of Texas, LLC dba Flourish Research San Antonio, Texas, United States Site recruitment: Not reported
Hormone Receptor-Positive Breast Cancer; HER2-Negative Breast Cancer
Sponsor
Rutgers, The State University of New Jersey
Countries with listed sites
United States
Registry dates and results
Start: 2024-10-30. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug) — also listed as: LY3298176 (development code name), Mounjaro (brand name in certain regions), Zepbound (brand name in certain regions)
Where the study takes place — 7 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Trinitas Comprehensive Cancer Center Elizabeth, New Jersey, United States Site recruitment: Recruiting
RWJ Barnabas Health - Robert Wood Johnson University Hospital, Hamilton Hamilton, New Jersey, United States Site recruitment: Not yet recruiting
RWJBarnabas Health - Cooperman Barnabas, Livingston Livingston, New Jersey, United States Site recruitment: Recruiting
RWJBarnabas Health - Monmouth Medical Center Long Branch, New Jersey, United States Site recruitment: Recruiting
Rutgers Cancer Institute New Brunswick, New Jersey, United States Site recruitment: Recruiting
RWJBarnabas Health - Newark Beth Israel Medical Center Newark, New Jersey, United States Site recruitment: Recruiting
RWJ Barnabas Health - Robert Wood Johnson University Hospital, Somerset Somerville, New Jersey, United States Site recruitment: Recruiting
Start: 2026-01-20. Completion: 2027-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Treatment with tirzapatide (drug)
Treatment with placebo (drug)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2025-05-23. Completion: 2026-12-30 (may be estimated). No results posted in this registry response.
Products and interventions (0)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Laiko General Hospital Athens, Attica, Greece Site recruitment: Recruiting
Start: 2024-04-15. Completion: 2025-11-21 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
LY3841136 (drug)
LY3841136-Placebo (drug)
Tirzepatide (drug)
Tirzepatide-Placebo (drug)
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
P-One Clinic Hachiōji, Tokyo, Japan Site recruitment: Not reported
Sumida Hospital Sumida-ku, Tokyo, Japan Site recruitment: Not reported
Hakata Clinic Fukuoka, Japan Site recruitment: Not reported
Start: 2025-04-08. Completion: 2027-06-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug) — also listed as: Zepbound
Placebo (drug) — also listed as: Normal Saline
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Cleveland Clinic Cleveland, Ohio, United States Site recruitment: Recruiting
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.
